Skip to content

The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease

The Effect of Patient's Perceptions for COVID-19 on the Inflammatory Bowel Disease-related Healthcare Utilization in the Hyperepidemic Area

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04387279
Enrollment
800
Registered
2020-05-13
Start date
2020-04-24
Completion date
2021-03-30
Last updated
2020-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Facilities and Services Utilization, Perception, Self

Brief summary

The rapid spread of COVID-19 is expected to have a significant impact on medicine as well as all sectors worldwide. In particular, inflammatory bowel disease (IBD) is a chronic immune disease in which remission and activation are repeated and must be treated consistently throughout life. In addition, patients with IBD may be vulnerable to various infectious diseases due to the immuno-compromised state due to the use of immuno-suppressants or biological agents. During a pandemic, patients with IBD may postpone hospital visits due to concerns about infection with COVID-19, and if they cannot continue drug treatment, there is a concern about the flare up IBD disease activity. Therefore, in this study, we would like to investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital ultilization.

Detailed description

Background: In the epidemic area of COVID-19, emergency treatment of chronic diseases other than COVID-19 can be limited. Therefore, it is important to reduce the risk of exposure to COVID-19 in patients with chronic immune diseases such as IBD, but it is most important to manage well so that the underlying diseases are not exacerbated at times when emergency medical treatment may be difficult. However, there is a lack of evidence on the management policy of chronic immune diseases in the current epidemic, and only expert opinions are being presented. Aim: To investigate the current status of hospital utilization of IBD patients in Daegu, the epidemic area of COVID-19, and to investigate the effect of patient perception of COVID-19 on hospital utilization. Material and method: This study is a multicenter, prospective, cross-sectional survey which will be consulted in Keimyung University Dongsan Medical Center and Yeungnam University Hospital. Patients with IBD aged above 18 will enrolled and surveyed about their perception about COVID-19 and status of hospital utilization during pandemic period. Patients' demographics and disease-related variables will be evaluated to identify clinical significances.

Interventions

OTHERInterview

Surveys on medical use patterns and patient's perceptions about COVID-19

Sponsors

Yeungnam University College of Medicine
CollaboratorOTHER
Keimyung University Dongsan Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with inflammatory growth disease, those who agreed to participate in this study

Exclusion criteria

* Those who are unable to understand or answer the questionnaire * Those who declined to participate in this study

Design outcomes

Primary

MeasureTime frameDescription
Patient's perception of COVID-19 and medical use patterns1dayCorrelation between patient's perception of COVID-19 and medical use patterns during the pandemic period

Secondary

MeasureTime frameDescription
Exacerbation of symptoms1dayExacerbation of symptoms in patients with IBD during the pandemic period

Countries

South Korea

Contacts

Primary ContactYoojin Lee, M.D.
doctorlyj@naver.com82-53-258-7739
Backup ContactKyeong Ok Kim, Ph.D.
kokim@yu.ac.kr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026